RSV
ACIP Recommends Expanded Use for RSV Vaccines
In a unanimous vote, the CDC’s ACIP voted to expand its recommendation for the use of respiratory syncytial ...
APRIL 17, 2025
FDA Grants Expanded Indication for GSK’s Arexvy
The FDA granted a new indication for GSK’s Arexvy adjuvanted respiratory syncytial virus vaccine to prevent ...
JUNE 13, 2024
CDC, FDA Expedite Additional Doses of Beyfortus for Infants
The CDC announced 77,000 additional doses of nirsevimab-alip, a long-acting monoclonal antibody designed to protect ...
NOVEMBER 17, 2023
Pediatricians: We Need Infrastructure to Provide Nirsevimab
There might be several obstacles to administering Beyfortus. Pediatricians are going to need help overcoming them.
AUGUST 10, 2023
CDC Recommends Universal Beyfortus to Protect Infants Against RSV
The CDC recommended a new monoclonal antibody to protect young infants from RSV. Even though it is not technically ...
AUGUST 4, 2023
Beyfortus Approved to Prevent RSV in Infants & Children
The FDA approved Beyfortus (for the prevention of RSV lower respiratory tract disease in newborns and infants born ...
JULY 18, 2023